Compare FFBC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFBC | TWST |
|---|---|---|
| Founded | 1863 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 2003 | 2018 |
| Metric | FFBC | TWST |
|---|---|---|
| Price | $27.99 | $49.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $30.00 | ★ $45.75 |
| AVG Volume (30 Days) | 676.4K | ★ 999.6K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | 10.83 | ★ 63.89 |
| EPS | ★ 2.66 | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $27.55 | $18.91 |
| Revenue Next Year | $4.31 | $15.07 |
| P/E Ratio | $10.55 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $21.18 | $23.30 |
| 52 Week High | $31.38 | $57.88 |
| Indicator | FFBC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 57.71 |
| Support Level | $23.14 | $41.65 |
| Resistance Level | $31.38 | $57.88 |
| Average True Range (ATR) | 0.58 | 2.98 |
| MACD | 0.17 | 0.44 |
| Stochastic Oscillator | 85.10 | 89.04 |
First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.